Chart Outline
Chart Outline
Regulation D
§4(a)(2) Rule 504 Rule 505 Rule 506 Reg. A Rule 701
Statutory PRIVATE §3(b) Limited § 3(b) Limited If 506 met, Safe Harbor- §3(b)(1) & (b)(2) Limited §3(b) Exemption
Offering Exemption Offering Exemption (deemed to meet 4(a)(2)) Offering Exemption For Offers/Sales of
OFFERing Exemption Meet all req’s of 501/502 - Mini Public Offering Comp. Benefit Plans
Issuer NO Reporting OR - NO Investment - Available ONLY for NO Exchange Act NO Reporting
Qualification Investment Companies issuer NOT to its Reporting Enterprises Companies
NONE Companies - Bad-Actor affiliates or SHers, - Bad-Actor Disqualifier
(see print off for stuff
- States may have Disqualifier apply AND NOT to apply (see below) AND ONLY for
to add to 506) certain bad-actor (see below) subsequent sellers - Common for private Employee Comp; no
disqualifiers - Dodd-Frank adds bad- issues of E’e stock options exemption for raising
actor disqualifiers (esp. for Non-Accred) capital
Aggregate $1 million (w/in 12 $5 million (12 mos.) §3(b)(1) - $5 million (12 Greater of: (1) $1
Offering Price Unlimited mo. rolling period) - aggregate w/ other Unlimited mos.) million; (2) 15% of
offers under 3(b)(1) §3(b)(2) – JOBS Act assets; or (3) 15% of
Limits Unlike 506, 4(a)(2) offering Aggregate w/ other CLASS of Exempt outstanding securities
issuer doesn’t need to provide offers under 3(b)(1) Aggregate w/ other Securities (never have to class being issued in
info (as long as investor has and Rule 505 offers under 3(b)(1) be registered - $50 million past 12 mos.
access) so in offering of and Rule 504 (12 mos.) - NO exemption for
relatively small amounts OR offers/sales intended
selling stock in CHC, 4(a)(2) § 4(a)(5) – offers & sales to raise capital
is better to accrediteds exempt IF -NOT aggregated w/
total offering >$5 MM other offerings
502(a) – Integration 502(a) – Integration 502(a) – Integration NOT integrated w/ PRIOR All offers and sales
applies applies applies offers or sales of securities pursuant to 701 are
None deemed to be a part
Integration 6 month safe harbor 6 month safe harbor 6 month safe harbor 6-month safe harbor of a single, discrete
BEFORE and BEFORE and BEFORE and AFTER offering (so NO
AFTER w/ other AFTER w/ other Reg w/ other Reg D 504/505 could integrate if integration into any
Reg D offerings D offerings offerings follows other offering made
by the issuer)
Number of Uncertain, BUT evidently a 35 + unlimited # of 35 + Unlimited # of Unlimited, BUT must
Investors finite number of offerees (see Unlimited (504(b)) accredited investors accredited investors – Unlimited be an eligible
Purina – if too many = public) – 505(b)(ii) – 501(e) (Reasonable belief) purchaser
reasonable belief BUT NO underwriters
- Focus on offeree and None required – NO NO sophistication - Purchaser MUST be - None required Purchaser MUST be
Investor purchaser need for issuer to requirements - NO sophisticated (alone or - reason it’s commonly employee, director,
- If any invalid or prohibited determine whether requirement that the w/ rep.) - $1M+ = OK used for private issuers of officer, consultant, or
Qualification offer, entire exemption voided the purchaser is investor have a - Accrediteds presumed employee stock options, advisor of an eligible
Must have a reasonable
belief on this
(rescission) sophisticated (or purchaser to qualify (reasonable especially when non- company who
(make sure to put this in - Offeree MUST be financially whether s/he has a representative belief) – 502(b)(1) & accredited, b/c that acquires the security
sophisticated (or w/ rep.) sophisticated institutions & wealthy eliminates 4(a)(2) and 506 as compensation
Regulation D
§4(a)(2) Rule 504 Rule 505 Rule 506 Reg. A Rule 701
Statutory PRIVATE §3(b) Limited § 3(b) Limited If 506 met, Safe Harbor- §3(b)(1) & (b)(2) Limited §3(b) Exemption
Offering Exemption Offering Exemption (deemed to meet 4(a)(2)) Offering Exemption For Offers/Sales of
OFFERing Exemption Meet all req’s of 501/502 - Mini Public Offering Comp. Benefit Plans
the Due Diligence file) AND Issuer MUST satisfy representative) individuals irrebutably options
Sophistication = INFO requirement deemed sophisticated
knowledge/experience Wealth NOT substitution - Non-Accreds have to
in business & finance to for sophistication (cf. 506 – be Sophisticated (or
evaluate merit/risks which is easier to satisfy) have purchaser rep)
- Offeree MUST receive OR 502(b)(2) - NO Rule 502(b) – IF Rule 502(b) – for §3(b)(1) –info from Reg. A No information
Information have access to type of info information needed non-accredited, NON-accredited, §3(b)(2) –Electronic filing specified EXCEPT IF
Registration would disclose to be given to delivery of info is delivery of info is to provide SEC & investors greater than $5
Requirements Offeree likely has “access” investors UNLESS required (even if required (even if offering statement; audited million sold – 701(e)
if high-level exec; family ties, required by state law sophist.) sophisticated) financials; describe - then give ERISA
privileged r’ship due to prior - If accredited, NO - If accredited, NO info operations, financial summary/material
business dealings; OR info delivery reqm’t needed to be given condition, corp. gov., use terms; risk factors; &
economic bargain power of funds, etc. some fin. statements
General Solicitation NO general solicitation or General Solicitation 502(c) - Traditional - 502(c) -No GS or Ads General solicitation
or Advertising advertising permitted or Advertising IF: Rule w/ no permitted in traditional General solicitation & & advertising IS
- G.S. = “lack of (1) state registered exceptions – NO Rule 506 offerings advertising IS permitted permitted
preexisting 4(a)(2) ONLY exempts from OR general solicitation or - Under JOBS
relationship” (H.B. registration reqm’ts (2) state allows & advertising permitted Act/506(c) – GS or Ads Under § 4(a)(5)) – no
Shane - questionnaire) transactions by an Issuer NOT sold ONLY to AIs permitted IF ALL GS&A (and must file w/
- Advertising = print, involving any “public” - 504(b)(i)-(ii) purchasers are verified SEC)
digital, TV, radio, etc. offering as accredited
Resale Limitation/ Restricted Purchaser must Restricted – 502(d) Restricted – 502(d) Restricted – 502(d) – NO resale restrictions Restricted – 701(g)
Holding Period hold for certain time (& Issuer --cant resell w/o ----cant resell w/o --cant resell w/o reg.. (UNrestricted) --cant resell w/o reg..
(Register OR Exemption) should do legend/stop order) reg.. OR exemption reg.. OR exemption OR exemption OR exemption
- 503 & 507 apply - 503 & 507 apply - Rule 503 & 507 apply §3(b)(2) –Required NO notice of sales
Filing with SEC NO notice of sales required - Form D required, - Form D required, - Form D required, but offering statement w/ SEC required to SEC
but not cond. of but not cond. of not cond. of exemption -must file audited financial
exemption exemption statements annually
Preemption and NSMIA preempts state State regulations do State regulations do - State law is State regulations do
Applicability of regulation of SEC rules/regs APPLY APPLY preempted by NSMIA, State regulations do APPLY
issued under 4(a)(2), BUT BUT must perfect APPLY
State Regulations states can impose their own exemption to preempt
- Earthboard Sports requirements for private - States can set forth
offerings that are exempt notice filing reqmts and
under the statute itself. bring fraud actions
Bad-Actor - No Fed bad-actor - Reg A 262 Applies to issuer; Reg A 262
Disqualifier? - BUT States may - Applies to issuer; D&O’s; 20% owners; - Applies to issuer; D&O’s;
Regulation D
§4(a)(2) Rule 504 Rule 505 Rule 506 Reg. A Rule 701
Statutory PRIVATE §3(b) Limited § 3(b) Limited If 506 met, Safe Harbor- §3(b)(1) & (b)(2) Limited §3(b) Exemption
Offering Exemption Offering Exemption (deemed to meet 4(a)(2)) Offering Exemption For Offers/Sales of
OFFERing Exemption Meet all req’s of 501/502 - Mini Public Offering Comp. Benefit Plans
Criminal convictions None listed have certain bad- D&O’s; 10% owners; promoters; invstmt 10% owners; promoters;
inv. securities w/in past actor disqualifiers promoters; invstmt mgrs.. and solicitors invstmt mgrs.. and
10 years; OR SEC/State mgrs.. and solicitors solicitors
disciplinary actions
Substantial Rule 508-Can raise in private suits, BUT NOT w/ Gov’tD must show
Compliance Defense N/A 1) Particular reqm’t not designed to protect complaining party N/A N/A
2) Failure to comply is insignificant to offering as a whole; AND
(if no reasonable 3) A good faith and reasonable attempt to comply w/ all Reg. D requirements
belief, then you lose) NOT IF: (1) GS&A violation; (2) over $ limit; or (3) 36+ Non-Accreds
POST-EFFECTIVE PERIOD
Rule 168 - Regularly released Permitted N/A Permitted Permitted Permitted Permitted
factual business information AND
forward-looking information by
reporting issuers
Rule 169 - Regularly released N/A Permitted, but only N/A N/A Permitted if EGC is a N/A
factual business information to persons other than Non-Reporting Issuer and
(excluding dividend notices) by in their capacities as only to persons other than
non-reporting issuers and investors. in capacity as investors.
voluntary filers
"Free Writing" as permitted by Permitted Permitted Permitted Permitted Permitted Permitted
Section 2(a)(10) NOT
“FWP” but carve out from
definition of “prospectus.”
Rule 134 Tombstone Notice Under Rule 134, Issuer may release general information about: (1) its business; (2) the terms of the securities being offered; (3) the underwriters of
the offering; (4) details on the offering process; (5) the anticipated schedule of the offering; (6) a description of marketing events; (7) indications of
interest and conditional offers to buy; and (7) the security rating that is reasonably expected to be assigned
**Only permitted AFTER filing of
Tombstone Ad is exempt from the definition of prospectus pursuant to Section 2(a)(10)(b)
Reg. Statement
o BUT term sheet used by issuer will be treated as a FWP subject to the FWP requirements
Allows the issuer to gauge the level of financial intermediary and investor interest in the prospective offering
o The SEC permits use of the Tombstone Ad prior to ascertaining a bona fide price range of the securities
Does NOT allow the issuer to set forth a detailed description of the securities
Rule 164 - Free Writing N/A Permitted if final Permitted if final Permitted Permitted if the EGC is Permitted
Prospectus = Offer prospectus delivered prospectus a Seasoned Issuer. If
w/ or before., AND delivered w/ or EGC is NOT a seasoned
No FWPs prepared before., AND issuer, permitted as long
or disseminated No FWPs as accompanied or
Rule 172 – Investors are through media if prepared and preceded by a final
Type of Communication Ineligible NON-Reporting Unseasoned Seasoned Emerging Growth Well-Known
Issuer Issuer Issuer Issuer Company Seasoned Issuer
presumed to have access to the paid for by issuer or disseminated prospectus.
Internet (Access = Delivery) UW unless through media if
accompanied or paid for by issuer
Rule 173(a) - Confirmation preceded by a final or offering
Statement is so that investors prospectus. participant
can Trace for Section 11 claim unless
(b/c they bought pursuant to a accompanied or
Reg. Statement) preceded by a
final prospectus.
Broker-Dealers (Rules 137, 138, 139)
Establish circumstances when broker dealers can publish research reports concerning issuers that propose to conduct a registered public offering
These safe harbors can be used in ANY period of the offering process
Waiting Period
a. Preliminary Prospectus
i. Extremely detailed, mandated disclosures. Must comply with Regulation S-K
ii. Not final prospectus because still in waiting period must be marked as a red herring
1. Sales are not allowed UNTIL prospectus is finalized (i.e. has pricing information)
iii. §2(a)(10)
b. Free Writing Prospectus
i. A writing that offers for sale the registered offerings of securities that does not meet the detailed disclosure requirements of a Section 10(a) final
prospectus (Rule 405)
1. FWPs may contain additional/supplemental info, but CANNOT conflict with the statutory prospectus
a. Statutory prospectuses are governed by §10 of SA
2. Use of FWP based on Issuer Class
a. WKSIs may use free writing prospectus during any phase of the offering but must contain a legend notifying the recipient where the
registration statement can be located (if one has been filed) (Rule 163)
b. Eligible seasoned issuers may use free writing but only if a registration statement containing a preliminary statutory prospectus has
been filed
i. Such a FWP must contain a legend identifying where the investor can access the statutory prospectus, a hyperlink to the
statutory prospectus, or the URL for the SEC website. (access = delivery)
c. Non-reporting issuers and eligible unseasoned issuers may use free writing prospectus if a registration statement has been filed with
the SEC and the free writing prospectus is accompanied or preceded by the most recent statutory prospectus (Rule 164)
ii. Confidential Review of IPO Registration Statements Filed by Emerging Growth Companies
1. Pursuant to JOBS, an emerging growth company may confidentially submit to the SEC its draft IPO registration statement for non-public review by the
Commission prior to the company’s public filing of such IPO registration statement
2. Any such confidential draft and amendments thereto MUST be publicly filed with the SEC at least 21 days before the date on which the company conducts
its road show for the IPO
3. This permits an EGC to initiate the IPO filing process without having to publicly disclosure sensitive information (to, amongst others, competitors)
a. However if the EGC elects to pursue the IPO, it MUST publicly file the confidential draft submission as set forth above – namely, at least 21 days
before conducting a road show for its IPO
iii. Media
1. Where information (Oral OR Written) about an issuer or an offering is provided by the issuer or any offering participant to the media and the information
is subsequently published and constitutes an offer to sell, it will be considered a FWP.
a. As such, these are allowed BUT the issuer is required to file with the SEC such written communications within 4 business days of first publication
2. Other obligations depend on whether the issuer prepared or paid for the publication
a. If an issuer prepares, pays for, or gives other consideration for the preparation or dissemination of the publication then the issuer MUST satisfy all of
the conditions for that type of issuer using a FWP
i. Non-reporting issuers and reporting unseasoned issuers MUST precede or accompany the communications with a statutory prospectus
AND file the media piece with the SEC
ii. A seasoned issuer that prepared or paid for the communication ONLY has to have filed a registration statement with the SEC AND file the
media piece
iii. Any WKSI may use such media piece at any time, subject to filing FWP with the SEC
b. If FWP is prepared and published by media persons unaffiliated with the issuer, and the issuer has participated but NOT prepared or paid for the
publication, the issuer’s (other than WKSI) obligations under Section 5 is to have filed a registration statement (and thereby a statutory prospectus)
with the SEC
c. Road Shows
i. Conducted to prospective institutional investors and securities professionals as a means to present the issuer and the securities offered in a favorable light and
determine the extent of the party’s interest
ii. Through a number of no-action letters, the SEC staff had acquiesced in the view that roadshow media does not constitute a Section 2(a)(10) prospectus and
allowed the use of electronic media by issuers and underwriters to conduct roadshows for audiences consisting of sophisticated investors and securities
professionals
1. Now a more detailed approach as to what constitutes written offers and prospectuses
a. The conducting of real-time roadshows to live audiences that are also transmitted graphically in real-time are NOT deemed written communications
or FWPs.
b. On the other hand, roadshows that do NOT originate live, and NOT in real-time to a live audience and are NOT graphically transmitted are electronic
roadshows that will be considered written communications and, therefore, free writing prospectuses.
The Post-Effective Period
Begins after the registration statement becomes effective
Sales of the subject securities may now be made, BUT ONLY IF a Section 10(a) final statutory prospectus has been provided OR is accessible to the purchaser
preliminary prospectus has certain incomplete info
o Access = Delivery (see below)
Written offers continue to be regulated by the SEC offering rules, such as the use of FWPs
The content of the final statutory prospectus are specified in Section 10(a)
o Final prospectus is used after the registration statement becomes effective
o During the post effective period, the section 10(a) final statutory prospectus must be provided or be accessible to purchasers of the subject securities
Access Equals Delivery
o The SEC adopted an access equals delivery framework to the Section 5 prospectus delivery requirement in the post-effective period (Rule 172)
Investors are presumed to have access to the Internet
Accordingly, issuers and other offering participant may satisfy the prospectus delivery requirement by posting the final statutory prospectus on a readily
available website
o Thus, the Section 5 requirement that a final statutory prospectus precede or accompany the delivery of the securities for sale has been eliminated provided that
the final statutory prospectus is timely filed with the Commission and is posted on readily accessible website
The SEC adopted a notification rule requiring dealers and underwriters to provide a Confirmation notice to purchasers that their purchase was pursuant to a
registration statement (Rule 173(a)) helps determine tracing (because offering was subject to that registration statement0
SECURITIES (’33) ACT – CAUSE OF ACTION CHART – also see Section 18 on ’34 Act Chart below and 29(b) below
Rule 10b-5 Section 11 Section 12(a)(1) Section 12(a)(2) Section 17(a)
Purchase OR Sale of Registered offering Unregistered, Exempt ANY written OR oral Sales AND Offers to
Coverage Securities (jdx – use of item Offering comm’ns as part of Public Sell (doesn’t cover
in interstate commerce) Offering (Gustafson) fraud on the Purchase)
Acquirer of registered Purchaser of Purchaser of securities – SEC Enforcement
Plaintiff Purchaser OR Seller securities Tracing reqm’t unregistered securities strict privity reqm’t (NO private right)
Defendant Primary violator Issuer, Directors, specified “Seller” who solicits for “Seller” who solicits for Violating Seller or
Officers, Experts, UWers personal gain personal gain Offeror (e.g., Brokers)
Misrepresentation OR Untrue statement OR Violation of Section 5 Offer or Sale by oral offer Prohibits offerings,
Violation omission of material fact “in misleading omission of (sale or offer of OR prospectus containing whether registered or
connection w/ purchase or material fact in Reg. unregistered securities materially false or exempt, by false or
sale of any security Statement (+ Prospectus) OR gun-jumping) misleading statements misleading means
Culpability Scienter required (includes - Strict Liability for Issuer No scienter reqm’t, but NO scienter reqm’t - 17(a)(1) – scienter
Plead fraud /w recklessness, but negligence - Due Diligence defense for In Pari Delicto available Defense: Reasonable care - 17(a)(2) or (3) -
particularity is NOT enough) NON-Issuer D’s if P equally liable to D and NO knowledge negligence (Aaron)
Reliance required (unless NO reliance reqm’t – just
involves duty to speak OR NOT required (defense if show material misstatement
Reliance omission (Affiliate Ute) Income statement filed 12 N/A or omission But defense N/A
- Can use F.O.T.M. (Basic) months after offering) if purchaser knows untruth
for rebuttable presumption or omission (not justifiable)
- Transaction Causation – but No Causation reqm’t, but No causal connection NO loss causation reqm’t
Causation for violation, transaction would Defense = all/part of loss required btw violation Defense = all/part of loss N/A
not have occurred caused by unrelated market and price drop caused by unrelated factors
- Loss Causation – injury factors (down to 0)
attributable to D’s act
Generally, out-of-pocket Damages = difference btw - Rescission (if P owns) - Rescission (if P owns) Civil injunctions and
Remedy damages amount paid & value when - Rescissory damages (if - Rescissory damages (if penalties in court;
sold OR time of suit already sold) already sold) C&D orders
Proportional liability for Proportional liability for
Limited Liability unknowing violators unknowing outside directors N/A N/A
Contribution Available Available N/A N/A
Aider & Abettor No private right of action No private right of action No private right of No private right of action
Liability (Central Bank of Denver) action
-In SEC actions, A&A if
party knowingly/recklessly
provides help to primary P
Controlling Person Investors can also recover, on a joint & several basis, from persons (individuals or
Liability – Section 15 corporations) who control any person liable under Section 11 or 12, unless D had NO
knowledge of OR no reasonable grounds to believe in existence of facts
Limitations Period 2 years after discovery 1 year after discovery 1 year after discovery 1 year after discovery 2 years after discovery
5 years after violation 3 years after sale (maybe 3 years after offering 3 years after offering (maybe 2 5 years after violation
2 years/5 years, if fraud) years/5 years, if fraud)
EXCHANGE (’34) ACT – CAUSE OF ACTION CHART – also see Section 17 on ’33 Act Chart above and 29(b) below
Rule 10b-5 Section 18(a) – used more by Section 9(e) Section 20(a)
Institutional investors & no class (see § 10 & 14(e) & 15(c))
action
Trading in Exchange-listed Control Person liability
Coverage Purchase OR Sale of Securities SEC Filing Security (and Inside Trading )
Purchaser OR Seller Purchaser OR Seller of Purchaser OR Seller of For SEC actions ONLY
Plaintiff affected Securities manipulated Securities
Requirements:
Primary violator Person who makes false “willful participant” in
statements in filing manipulative conduct (1) A primary
Defendant
securities law
Fraud/deceit, misrepresentation OR False or misleading statement Specified manipulative practices violation by another
Violation omission of material fact “in connection w.r.t. to material fact in SEC (wash sales, matched orders, (i.e. violation of
w/ purchase or sale of any security filing etc.) §10(b)),
Culpability Scienter required (includes recklessness, Defense: good faith & NO Required (“willful participation” (2) substantial
Plead fraud /w but negligence is NOT enough) knowledge of falsity that assistance by alleged
particularity statement was aider/abettor in the
false/misleading commission of
Reliance required (unless involves duty to Reliance required – P must primary violation;
speak OR omission (Affiliate Ute) show that he actually read the N/A AND
Reliance - Can use Fraud-on-the-Market (Basic) to relevant parts of the document
(3) the secondary
establish presumption of reliance, but D in question either by reading
can rebut by showing reliance NOT the filed document itself or as
actor’s knowledge of
reasonable (b/c adequate truthful info) described in another source OR recklessness as to
- Transaction Causation – but for “price affected by statement” price affected by violation that primary
violation, not have occurred Loss Causation AND violation
Causation - Loss Causation – injury attributable to Transactional Causation
D’s act in reliance on such materially Substantial Assistance
false or misleading statement,
that P purchased or sold security Defendant (1) in some
at a price that was affected by the sort associated himself
disclosure deficiency
with the venture, (2) that
Remedy Generally, out-of-pocket damages Damages caused by reliance Damages as result of violation
he participated in it as in
Limited Liability Proportional liability for unknowing N/A N/A something he wished to
violators bring about, (3) and that
Contribution Available Available Available he sought by his action
Aider & Abettor No private right of action (Central Bank of Denver) to make it succeed (SEC
Liability v. Apuzzo)
Controlling Person In SEC actions, A&A if party knowingly/recklessly provides help to primary P
Liability – Section 20
Limitations Period 2 years after discovery 2 years after discovery 2 years after discovery
5 years after violation 5 years after violation 5 years after violation
Rule 14a-9 – Implied Remedy for Material Misstatements or Omissions in Proxy Materials – (TSC Industries)
o Rule 14a-9 prohibits material misstatements & omissions in connection w/ solicitation of proxies (not just mgmt’s)
o P must show that he was injured in connection w/ covered proxy solicitation, regardless if purchase OR sale or not
Corp. or shareholder has standing for proxy violation IF injury + casual connection btw violation & injury
Any SH entitled to vote on the proposal has a right to full disclosure & can sue for violation of proxy rules
NO scienter requirement, but a showing of negligent conduct will suffice (Aaron v. SEC)
o Materiality - the misstatement or omission must be of a character that there is ‘‘a substantial likelihood that a reasonable shareholder would consider it
important in deciding how to vote.’’ very factual (TSC Industries)
o Causation – Loss causation (connection between the misstatements/misrepresentation and the actual damages/economic harm resulting from the transaction)
AND transaction causation (= But-for causation, and demonstrates that the misstatements or omissions were causally related to the occurrence of the
transaction) (Dura)
Section 14(e) – Tender Offer Fraud
o Section 14(e) prohibits fraud, deceit, and material misrepresentations OR omissions in connection w/ any tender offer OR request or invitation for tenders OR
any solicitation of SHers to favor or oppose such offer, request, or invitation requires full and fair disclosure of the tender offers’ terms (no price reqm’t)
o NOT limited to tender offers of just ’34 Act registered reporting companies – Applies even to non-public companies
o P must show some misrepresentation OR nondisclosure AND that D acted w/ scienter
o Rule 14e-3 – prohibits insider trading during a tender offer (applies to insiders of target company AND anyone else)
o Applies a strict PARODY of INFORMATION rule – broadest application of insider trading rules applies Disclose-OR-Abstain provision when a person is
in possession of material information relating to a tender offer AND knows or has reason to know that such info is non-public AND obtained directly or
indirectly from Bidder, Target corporation, any of their affiliated persons, OR anybody acting on behalf of either company.
Generally, the rule (with certain exceptions) contains broad “disclose OR abstain from trading” provisions AND “anti-tipping” provisions.
o Forward-looking statements for purposes of the Reform Act’s safe harbor include:
Those that “contain[] a projection of revenues, income (including income loss), earnings (including earnings loss) per share, capital expenditures,
dividends, capital structure, or other financial items,” those that are “statement[s] of the plans or objectives of management for future operations,”
and those that are “statement[s] of future economic performance.”
o The Reform Act safe harbor states that a person is not liable for a forward-looking statement if the statement is (1) immaterial or accompanied by cautionary
statements; OR (2) if the plaintiff fails to prove that the statement was made with actual knowledge that the statement was false or misleading.
o The Reform Act’s safe harbor has no state of mind requirement; if cautionary language is adequate, the inquiry ends there.
Even if a forward-looking statement is deliberately false, cautionary statements will protect the author from any liability, pursuant to the plain
meaning of the safe harbor provisions.
o “[U]nder the literal language of the safe harbor statute the author of any forward-looking statement — even though a deliberate falsehood — is insulated
from liability so long as that statement is accompanied by some meaningful cautionary statement.”).
If forward-looking deliberate falsehoods are not accompanied by adequate cautionary language, however, the safe harbor will not apply.
To immunize a forward-looking statement, “the cautionary language must be precise and must directly relate to the defendants’ forward-looking statement.”
Acceptable cautionary language includes warnings that are specific and linked to the challenged projections.
o “General statements that fail to disclose specific underlying material information fail to trigger the protection [of the safe harbor].
o Likewise, boilerplate warnings merely reminding an investor that the investment holds risks are not sufficient.”
Written only, or is oral cautionary language sufficient?
Federal and State Law
Section 16 of the Securities Act and § 28(a) of the Exchange Act explicitly preserve remedies existing prior to passage of the securities acts. Thus, the
federal securities laws do not preclude state law actions, such as actions for common law fraud, arising out of securities transactions.
Securities Act - Actions under the Securities Act can be brought in either federal or state courts, under § 22(a) of the Securities Act.
Exchange Act - Section 27 of the Exchange Act requires actions under the Exchange Act to be brought only in the federal courts.
SLUSA - These provisions make federal court the exclusive venue for nearly all securities fraud class actions
o SLUSA preempts certain class actions that allege fraud under state law and effectively makes federal court the exclusive venue for nearly all
securities fraud class actions.
o Specifically, SLUSA precludes a private party from bringing a “covered class action” in federal or state court based on state law alleging a
“misrepresentation or omission of a material fact” or the use of “any manipulative or deceptive device or contrivance in connection with the
purchase or sale of a covered security.”
The term “covered securities” in SLUSA includes those listed or authorized for listing on the New York Stock Exchange, the American
Stock Exchange, or the NASDAQ Stock Market.
o Covered class actions brought in state court are removable to federal court and the state law claims are subject to dismissal based on the
preemption provisions in § 16(b) of the Securities Act and § 28(f)(1) of the Exchange Act The party seeking removal must establish that the
action is “(1) a ‘covered class action,’ (2) thatis based on state law, (3) alleging a misrepresentation or omission of a material fact or use of any
manipulative or deceptive device or contrivance, (4) ‘in connection with’ [or ‘involving,’ for removal purposes], (5) the purchase or sale of a
covered security.”
Liabilities Under the SECURITIES ACT (primarily protects purchasers)
Overview of § 11 and § 12
Sections 11 and 12 Contrasted
Sections 11 and 12 are the basic private liability provisions of the Securities Act and only buyers, NOT sellers.
Section 11 makes those responsible for a false or misleading registration statement liable in damages to any and all purchasers
regardless of from whom they bought
Section 11 deals with the “manufacturers” and “wholesalers” of securities (i.e., issuers, underwriters and experts who aid them
in preparing registration statements)
Has NO privity requirement
Provides a remedy in damages.
Section 12 allows a purchaser to rescind his purchase of securities, or to get damages from his seller if he no longer holds the securities,
if the seller used a false or misleading prospectus or false or misleading oral statements in making the sale.
Section 12 deals with “retailers” of securities (i.e., the securities dealers who sell to the general public),
Requires privity
Provides primarily for a remedy of rescission.
Overlap Between § 11 and § 12
Anyone who buys a security directly from an issuer OR underwriter that is unregistered in violation of § 5 of the Securities Act OR on
the basis of false or misleading oral representations or a false or misleading prospectus may have an action for rescission under § 12 as
well as an action under § 11.
Example: An underwriter liable under § 12(2) and an issuer could e liable under § 12(1)
Exclusivity of § 11 or § 12 Remedies
A buyer may NOT rescind or recover damages from his seller under § 12 AND THEN ALSO recover damages from an issuer,
underwriter or their advisors under § 11. Nothing prevents a litigant, however, from pursuing both § 11 and § 12 actions to judgment
and then electing his remedy.
Rule 9(b) and § 11 and § 12
Rule 9(b) applies to § 11 claims if the § 11 claims rely on the same alleged misrepresentations as a plaintiff’s 10(b) fraud claim
Requires § 11 claims “based on averments of fraud” to meet the heightened pleading requirements of Rule 9(b)
SECTION 11 – pertains ONLY to PUBLIC offerings (and registration statements used therein)
Section 11(a) makes specified persons liable for any untrue statement of material fact in a registration statement [in a Public Offering] OR any omission of any
material fact required to be stated in a registration statement or necessary to make statements therein not misleading, to any person acquiring the relevant security
UNLESS the acquiror knew of such untruth or omission at the time of the acquisition.
Persons Liable
o If a registration statement is false or misleading, § 11(a) makes liable:
the issuer;
the directors of the issuer; [Outside vs. Inside Directors? Read BarChris]
persons named, by their consent, in the registration statement as about to become directors of the issuer;
every expert (e.g., accountant, auditors, engineer, appraiser, etc.) who is named by consent as having certified or prepared
o What about Attorney opinion letters?
o All of the above, EXCEPT experts, are responsible for ALL misstatements and omissions in the registration statement.
Experts are responsible for misstatements and omissions only in those parts of the registration statement they are named as having prepared or
certified (in the Expertised portions)
The degree of investigation required of experts, such as accountants, is largely determined by professional standards holding that even a
concurring partner on an audit must adhere to norms of accounting profession
o These cases establish that whether a § 11(b)(3) defense exists must be determined on a case-by-case basis and the magnitude of the duty imposed will vary
by party.
Management and inside directors of the issuer will be under the highest duty to investigate the truth of the registration statement. nder § 11,
“[l]iability against the issuer of a security is almost absolute, even for innocent misstatements;
Other defendants may resort to a due diligence defense”).
Outside directors are under a lesser duty to investigate than are inside directors, see Rule 176(e). Nevertheless, they must also investigate to some
extent and cannot merely accept management’s representations that the registration statement is accurate.
Scienter
o A § 11 plaintiff does NOT need to establish a defendant’s scienter, or even negligence, to prove his case, because § 11’s liability provisions
create “‘virtually absolute’ liability” do not require plaintiffs to allege that defendants possessed any scienter.
o BUT under Section 27A(c) of the Securities Act, no liability will attach in a private action based on certain statutorily defined “forward-
looking statements” UNLESS the plaintiff proves actual knowledge of the false or misleading nature of the statement on the part of a natural
person making the statement or on the part of an executive officer approving the statement made on behalf of a business entity.
Section 11 Defenses
o An ISSUER has virtually no defenses under § 11: it is strictly liable for material misstatements and omissions in registration statements of public offerings.
However, a defendant can avoid liability by proving the plaintiff knew of the misstatements or omissions it is insufficient to state a claim under
Section 11 (or 12) unless the statement was both “objectively false AND disbelieved by the defendant at the time it was expressed.”
o All other defendants have a variety of defenses under § 11(b), for all of which they bear the burden of proof.
Due Diligence Defense - § 11(b)(3)- All defendants EXCEPT the issuer may escape liability by establishing certain defenses, among them one of
“reasonable grounds to believe” in the truth of the alleged misstatements or omissions contained in the registration statement Standard of
reasonableness is “prudent man in management of his own property”
Section 11(b)(3) in effect divides the registration statement into three portions:
Section 11(b)(3) then gives different defenses to experts and nonexperts with regard to misstatements or omissions in these different parts of the
registration statement:
o Experts— With regard to parts of the registration statement based on their own statements, reports or valuations, experts can establish a
defense by showing either (i) that after reasonable investigation they had reason to believe in the truth of their statements, reports or
valuations or (ii) that the registration statement did not fairly represent their statements or reports. Experts have no liability for portions of
the registration statement they are not named as having prepared or certified.
o Non-experts— With regard to parts of the registration statement based either on official reports or statements or on the reports or statements
of experts, a non-expert can establish a defense by showing that he had no reason to believe that such statements or reports were false or
misleading or were inaccurately represented in the registration statement. To this extent, nonexperts are allowed to rely on experts and on
official statements and reports. BarChris
Example: “An underwriter need not conduct due diligence into the ‘expertised’ parts of a prospectus, such as certified financial
statements.”
BUT With regard to other parts of the registration statement, a non-expert must show that he conducted a reasonable investigation,
and that, after such investigation, he had reasonable grounds for believing, and did believe, that the registration statement was
neither false nor misleading.
o Underwriter Due Diligence
o BarChris - Underwriters, to effectuate the statute’s purpose of providing full disclosure to investors, are placed under a high duty to investigate.
They cannot accept an issuer’s representation of facts about itself at face value, but must make an independent attempt at verification.
o Use following factors in assessing the reasonableness of an underwriter’s investigation:
(1) whether it is familiar with the issuer’s finances, management, and operations; (2) whether it had relevant industry knowledge; (3)
whether it interviewed the issuer’s employees; (4) whether it interviewed the issuer’s suppliers or customers or confirmed data with them;
and (5) whether it obtained verification from the issuer and its outside accountant that the prospectus was accurate. The underwriter’s duty
to investigate lasts up to the effective date of the offering.
o The SEC has suggested that each underwriter must satisfy itself that the lead underwriter’s investigation is sufficient, stating that each underwriter
“must show that he conducted a reasonable investigation of the registration statement . . . or a reasonable investigation of the [lead underwriter’s]
methods”)
Reliance
o A plaintiff, in almost all cases, need NOT show that he relied on statements in a registration statement to recover under § 11, as courts have interpreted § 11
to establish a presumption of reliance upon the registration statement.
o Additionally, under § 11(a), when the plaintiff buys the security after an earnings statement has been published for the issuer covering at least 12 months
since the effective date of the registration statement, the plaintiff must show reliance; but he need not, by the terms of the statute, show that he actually read
the registration statement.
Measure of Damages
o Under § 11(e), the measure of a plaintiff’s damages is the decline in the value of his securities.
This is measured as the difference between the price at which the securities were bought (not to exceed the price at which the securities were offered
to the public) and the price at which the securities were sold, if the securities were sold before suit was filed, or the price as of the date the suit was
filed, if the securities are still held as of that date.
o There is no upper limit, other than the total value of the offering in question, to the liability under § 11 of defendants other than underwriters.
Under § 11(e) no underwriter can be liable for more than the offering value of the securities underwritten by that underwriter, unless such
underwriter received special compensation from the issuer that other underwriters did not receive.
o Punitive damages are not recoverable under either the Securities Act or the Exchange Act.
Reliance
o It is universally held that a plaintiff does not need to establish any form of reliance to recover under § 12(1) or (2)
Remedies and Measure of Damages
o The primary remedy provided by § 12 is rescission: plaintiff tenders his securities to defendant and receives his purchase price, with interest, in
return. Interest is computed at what the court deems an equitable rate.
o Where plaintiff has received income, i.e., dividends or interest, on his securities, this income is subtracted from the purchase price in
determining what he will get upon tendering his shares.
o Where plaintiff has, before the filing of suit, disposed of the relevant securities, and thus cannot rescind the sale, he may recover
damages, measured as the difference between the purchase price and the disposal price of the securities, plus interest, and less any
income from the security received by the plaintiff. This measure of damages is intended to provide the equivalent of rescission.
o § 12(b) of the Securities Act, which provides that if a defendant in a § 12(2) action shows that all or a part of the security’s diminished value
was not caused by the misstatement or omission alleged in the complaint but rather by some other cause, the plaintiff may not recover damages
attributable to that other cause
o The defendant bears the burden of showing this absence of loss causation.
Statute of Limitations
o Both § 12(1) and § 12(2) are subject to the limitations periods set forth in § 13 of the Securities Act.
o Actions under § 12(1)must be brought within the shorter of one year of the date of the violation, or three years from the date the security
was first offered to the public.
o Actions under § 12(2) must be brought within one year of the discovery of the untruths or omissions, or one year from the time such
discovery should with reasonable diligence have occurred, and in no event more than three years after the relevant sale.
Standing
o Gustafson v. Alloyd Co - limited standing under § 12(2) to securities transactions that require a prospectus
o ONLY purchasers, NOT sellers, of securities have standing under §§ 11 and 12.
Section 17
Section 17 is the general antifraud provision of the Securities Act. Section 17 applies to any purchase of securities, whether or not part of a public offering
o Sections 17(a)(1), (2) and (3), respectively, prohibit use of any means of interstate commerce:
o (1) to employ any device, scheme or artifice to defraud,
o (2) to obtain money or property by means of material misstatements or omissions; OR
o (3) to engage in any course of business that would operate as a fraud upon a purchaser.
o In keeping with the general scheme of the Securities Act, § 17 protects ONLY purchasers and operates only against sellers, unlike § 10(b) of the Exchange
Act, which operates against both purchasers and sellers.
Private Right of Action Under § 17(a)
o Unlike §§ 11 and 12, § 17 does not expressly create a private right of action. It has been important primarily in actions brought by the SEC pursuant to §
20(b) of the Securities Act, which authorizes the SEC to seek injunctions against violations of the Act, and in criminal actions brought by the Justice
Department pursuant to § 24, which imposes criminal liability for willful violations of the Act.
o The growing consensus is that NO private right of action exists under § 17(a)
The Contrast Between § 17(a) and § 10(b)
o Ernst & Ernst v. Hochfelder, (SCOTUS) and Aaron (SCOTUS)- shattered the assumption that § 10(b) and § 17(a) are parallel provisions.
o The Hochfelder Court ruled that scienter is required to be shown in private actions under § 10(b).
o The Aaron Court ruled that scienter is required in SEC injunctive actions under § 10(b) and under § 17(a)(1), BUT NOT under § 17(a)(2) or (3).
o If an action can be framed under § 17(a)(2) or (3), as virtually any action against a seller under § 10(b) or § 17(a)(1) can be, it can be tried under a
negligence, rather than a scienter, standard.
o Thus, the prospect existed after Aaron that there could be a private right of action against sellers under § 17(a)(2) or (3) that would be more
attractive to plaintiffs than that under § 10(b). The reaction of lower courts to this prospect has been to shrink back, and either not to recognize a
private right of action under § 17(a), or to limit it to actions that could in any case be brought under § 10(b)
Scienter
o Based on an analysis of the language of § 17(a), that scienter is a necessary element of the SEC’s case in an injunctive action under § 17(a)(1), but not under
§ 17(a)(2) or (3).
o Moreover, courts have recognized that virtually any action against a seller that can be brought under § 10(b) or § 17(a)(1) can also be brought under § 17(a)
(2) or (3), since virtually any “device . . . to defraud” that violates the former provisions will “operate as a fraud” in violation of § 17(a)(3) OR involve
obtaining money or property by means of misstatements or omissions in violation of § 17(a)(2).
o Thus, Aaron encourages the SEC to plead under § 17(a)(2) or (3) rather than § 10(b) or § 17(a)(1);
Standing
o A number of those courts that have implied private rights of action, mostly following the formerly accepted view that § 17(a) simply tracks § 10(b) but is
limited to actions against sellers, have held that there is a “purchaser” requirement under § 17(a), just as there is a “purchaser-seller” requirement under §
10(b), and hence that only one who has actually purchased securities can bring an action under § 17(a).
Persons Liable
o There is no privity requirement under § 17(a), and that a plaintiff is therefore not limited to suing his direct seller under § 17(a).
Reliance
o In those courts, if any, in which a private right of action under § 17(a) still exists, P will probably be required to plead and prove reliance.
o Holding of Affiliated Ute Citizens of Utah v. United States,—which was brought under § 10(b) of the Exchange Act—that, where material omissions are
charged, reliance is presumed if materiality is shown, had also been applied under § 17(a).
o By contrast, the government need never prove, in SEC injunctive or criminal actions under § 17, reliance by individual investors.
Remedies and Damages
o The remedies available in private rights of action under § 17(a) have included rescission and damages. The majority view is that punitive damages are not
available under § 17(a).
Statute of Limitations
o The limitations period for civil actions under § 17 is not expressly governed by the provisions of § 13 of the Securities Act.
o Sarbanes-Oxley’s extended statute of limitations for securities law violations that sound in fraud to two and five years should apply to § 17 claims, as it does
to claims under § 10 of the 1934 Act.